Cellnovo Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Employees
  • 92

Employees

  • Latest Deal Type
  • Liquidation

Cellnovo General Information

Description

Cellnovo Group SA is engaged in the development of a system for diabetes management. The product portfolio includes cordless micro-pump, an integrated monitoring device and a cellular handset with a touch screen with an embedded blood glucose meter.

Contact Information

Formerly Known As
Starbridge Systems, Starbarge Limited
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6, rue de Téhéran
  • 75008 Paris
  • France
Primary Industry
Monitoring Equipment
Other Industries
Medical Supplies
Vertical(s)
Corporate Office
  • 6, rue de Téhéran
  • 75008 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellnovo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 26-Apr-2019 Completed Bankruptcy: Liquidation
9. Debt - General 01-Aug-2018 Completed
8. PIPE 31-Jul-2018 Completed Generating Revenue
7. Debt - General 07-Jul-2017 Completed
6. PIPE 07-Jul-2017 Completed Generating Revenue
5. Debt - General 01-May-2017 Completed
4. IPO 10-Jul-2015 Completed Generating Revenue
3. Debt - General 01-Jul-2015 Completed
2. Later Stage VC (Series B) 21-Mar-2013 $45.8M $45.8M Completed Generating Revenue
1. Early Stage VC (Series A) Completed Startup
To view Cellnovo’s complete valuation and funding history, request access »

Cellnovo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series B1
Series A 8,103,333 $1.51 $1.51 $1.51 4.07%
To view Cellnovo’s complete cap table history, request access »

Cellnovo Patents

Cellnovo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201401586-D0 Actuator and actuation method Active 30-Jan-2014
GB-2525838-A Actuator and actuation method Active 30-Jan-2014
WO-2015114374-A1 Actuator and actuation method Inactive 30-Jan-2014
EP-3100188-A1 Handset device Active 30-Jan-2014
EP-3100188-B1 Handset device Active 30-Jan-2014 H04W52/0209
To view Cellnovo’s complete patent history, request access »

Cellnovo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellnovo Investments (1)

Cellnovo’s most recent deal was a Corporate Asset Purchase with TypeZero (Artificial Pancreas Technology). The deal was made on 18-Apr-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TypeZero (Artificial Pancreas Technology) 18-Apr-2017 Corporate Asset Purchase Buildings and Property
To view Cellnovo’s complete investments history, request access »

Cellnovo FAQs

  • When was Cellnovo founded?

    Cellnovo was founded in 2002.

  • Where is Cellnovo headquartered?

    Cellnovo is headquartered in Paris, France.

  • What is the size of Cellnovo?

    Cellnovo has 92 total employees.

  • What industry is Cellnovo in?

    Cellnovo’s primary industry is Monitoring Equipment.

  • Is Cellnovo a private or public company?

    Cellnovo is a Private company.

  • What is Cellnovo’s current revenue?

    The current revenue for Cellnovo is .

  • How much funding has Cellnovo raised over time?

    Cellnovo has raised $147M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process